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Rumah Sakit Caltex di Rumbai, Pekanbaru pernah melaporkan adanya P. falciparum yang resistent 
terhadap chloroquine. Setelah dilakukun follow up ternyata kasus ini ms ih  sangat sensitive terhadap 
group 4 aminoquinoline. 
Pada 'tahun 1973, seorang dokter yang bekerja untuk suatu pabrik obat menyebar luaskan desas-desus 
adanya P. vivax yang resistent terhadap chloroquine. 
Pembuktian penyelidikan oleh team Indonesia dan U S A .  Naval Medical Research Unit -2 Jakarta, pa& 
bulan Oktober 1973, ternyata P. vivax ditempat yang sama masih sensitive terhadap chloroquine. 
Kasus pertama P. falciph.rum yang resistent terhadap 4 aminoquinoline ditemukun pa& infeksi 
yaizg tejadi didekat Samrinda, Kalimantan Timur. 
Berdasar WHO - Sensitivity test, ternyata bahwa pada kusus tersebut terdapat adanya asexual panzsite 
resistent tingkat resistent I terhadap standard dosis dari 1.500 mg amodiaquine base dan standard dosis 
dari 1.500 mg chloroquine base. 
Resistance of ~lasmodium falciparum to 
chloroquine in Indonesia was mentioned by 
peters3, "In the region of Pekanbaru in the 
island of Sumatra'at least one RI response- 
appears certain, but other patients with acute 
falciparum malaria have responded normally to 
chloroquink therapy". This information ori- 
ginated from the Caltex hospital in Rumbai, 
Pekanbaru. In fact, follow-up of P. falciparum 
infections treated in this hospital shows that 
all were fully sensitive to 4-aminoquinolines 
ang that the above statement, based on a 
misunderstanding, should be disregarded. 
More recently (1973) rumors of P. vivax 
resistance to chloroquine (erythrocytic forms) 
in Timor have been spread by a physician 
working for a private pharmaceutical company. 
Despite careful1 examination of the duplicate 
slides, both in the Jakarta Malaria Reference 
Laboratory and in the Epsom WHO Malaria 
Reference Laboratory (England), no parasites . 
could be found in the slides said to show 
All P. vivax and P. falciparum cases responded 
satisfactorily to  chloroquine (1 500 mg base). 
In fact P. vivax parasites disappeared within 
48 hours in the 15 cases investigated and even 
within 24 hours in 11 of them, after receiving 
only the first 10 mg/kg base chloroquine. 
P. falciparum asexual forms also disappeared 
within 72 hours in the 33 cases studied. The 
extended 28 days test was not carried out. 
' WHO sensitivity tests were also carried out 
in North Sumatra by another Government/ 
USA-NAMRU team. Results were similar with 
no evidence of resistance in P. falciparum Or 
P. vivax. 
The following case history is therefore the 
first documented report of 4-aminoquinolines 
resistance in a strain of P. falciparum from 
Indonesia. 
THE CASE HISTORY 
A patient with repeated P. falciparum rec- 
rudescences after radical treatment. 
resistant parasites. The patient Paryadi, a young adult male, 
In October 1973 a USA- age 20, weight 58 kg, was found 'positive 
NAMRU team4 vjsited exactly the same area. (P. falciparum) on 17 May 1973 in Bantu1 
The WHO sensitivity test was carried out. Regency (Yogyakarta Province) shortly after 
returning from Kalimantan. 
1. WHO Medical Officer. Indonesia. He was given a standard radical treatment 
2. Chief Malaria Control Programme. Indonesia. of 1500 mg of amodiaquine base and 45 mg 
3. Peters. W. (1970) Chemotherapy and Drug Resis- 
tance in Malaria. Academic Press. primaquine over a period of 3 days, from May 
4. Cyrus and Gundel finger. personal communication. 18 to May 20. 
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On June 18 he was found again positive and 
given a second standard radical treatment from 
June 23 to June 25. 
On July 13 he was again found positive and 
given a third similar radical treatment but this 
time the amodiaquine was given and swallowed 
in the presence of the WHO malariologist. 
Duplicate slides were collected and the parasite 
count was carried out. 
On August 7 he was again found positive 
and given a fourth radical treatment from 
August 10 to August 12. 
On September 1st he was once more positive. 
This time 1500 mg chloroquine base were given 
and swallowed in the presence of the WHO 
malariologist. Duplicate slides were collected 
and the parasite count was carried out. 
On September 27 he was once again found 
positive. Treatment was postponed to allow the 
isolation of the strain with the assistance of 
NAMRU. 
A summary of the drugs given is shown in' 
Table 1. Over a period of '5 months from May 
17 to October 14 the patient has received a total 
of 12450 mg 4-aminoquinolines base (10350 
rng amodiaquine and 2 100 mg chloroquine), 
350 mg pyrimethamine and 225 mg primaquine. 
Table 1. Summary of treatments given t o  patient Paryadi 
Date Parasites 
Drug doses (in mg base) 
R e m a r k s  








































Single dose Systematic 
Single dose Symptomatic 
3 days 
Single dose Symptomatic 
3 days 
Single dose 
Single dose Symptomatic 
6 days Amodiaquine 
given by WHO 
Malariologist 
Single dose 
Single dose Symptomatic 
6 days 
Single dose Symptomatic 
Single dose 
6 days Chloroquine 




Single dose with 1000mg 
sulfadoxine 
* : see details in  following table 
Particulars on drug tablets : primaquine = Primaquine, Parke-Davis, 15 ml 
amodiaquine = Camoquin, Parke-Davis, 150 mg base chloroquine = Nivaquine, Specia, 100 mg bas 
pyrimethamine = Daraprim, Burroughs-Wellcome, 25 mg sulfadoxine = Fansidar, Roche, 500 mg plus 
25 mg pyrimethamine 
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The fact that the treatment (in addition to  
the doses given by the WHO malariologist) was 
given by a responsible supervisor living in the 
same Kampung, the rapid disappearance of the 
asexual forms after the schizontocidal treat- 
ment, the rapid disappearance of the gameto- 
cytes after the primaquine treatments, indicate 
that most, if not all, of the drugs were taken. 
The infection was terminated by a single 
dose of the combination of 1 .O g of sulfadoxine 
and of 50 mg of pyrimethamine on 22 October. 
Previously on 12 October blood samples 
were taken from the patient tobe sent,through 
Taipei NAMRU-TAMU Research Units, to 
Bethesda US Naval Hospital for inoculation into 
volunteers. Unfortunately these samples were 
lost between Taipei and Washington. 
The sensitivity tests. 
1. A modia'quine. 
After having received on July 13 a pre- 
sumptive treatment including 450 mg 
amodiaquine base and 50 mg pyrimethamint 
the patient, with an already low asexual para- 
sitaemia, was given the standard amodiaquine 
dose by the WHO malariologist. The asexual 
forms rapidly disappeared but on day 19, the 
patient was found again with a high para- 
Table 2. Results of test for P.falciparum strain sensitivity to a standard dose of amodiaquine in 
patient Paryadi. 
Parasites 
Date Day . Trophozoites Gametocytes Drug dose (mg base) R e m a r k s  
, Count per mm3 Count ' per rnm 3 
July 13 7 196 1372 0 0 amodiaquine 450 & Symptomatic 
pyrimetharnine 50 
.. 19 0 15 105 1 7 amodiaquine 600 amodiaquine 
.. 20 1 9 63 8 56 amodiaquhe BOO given by WHO 
,, 21 2 0 0 20 140 amodiaquine 300 malariologist 
.. 22 3 0 .O 30 210 primaquine 15 
, 23 4 - - - - prirnaquine 15 
.. 24 5 0 0 20 140 primaquine 15 
.. 25 6 0 0 4 28 
, 26 7 0 0 0 0 
.. 27 8 0 0 0 0 
.. 28 9 o o o o 
., 29 10 0 0 0 0 
, 30 11 0 0 0 0 
,, 31 12 0 0 0 0 
Aug. 1 13 0 , O  0 0 pyrimethamine 50 
0 0 0 0 .. 2 14 
.. 3 15 o 0 0 0 
.. 4 16 - - - - 
, 5 17 - - - - 
- ,,. 6 18 - - 
7 19 1440 10080 0 0 arnodiaquine 600 Sick since 
5 August. 
, 8 20 - - - - 
,, 9 21 - - - - 
,, 10 22 55 385 0 0 arnodiaquine 600 
, 11 23 0 0 2 only seen arnodiaquine 600 
in thick film 
, 12 24 0 0 lonlyseen amodiaquine 300 
in thick film 
* : count per 1000 leucocytes 
Conclusion : R1 resistance, delayed recrudescence. 
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sitaemia (10.000 trophozoites per nlm3). quine on the gametocytes, are given in Table 2 
Details. including the action of the prima- and are illustrated in Fig. I. 
. 
10.000 Asexual 
Paras i tes  , 00 
( per mm3) 
10 
Gametocytes 
(per  mm3)  1.000 100 
10 
Amodiaquine 600 
(mg base) 30 0 
-7 Primaquine 1 5 -  0 5 10 15 20 
( m g )  
I ~ ~ ~ I I I I I I I I I I I I I ~ ~  
0 5 10 15 20 
Pyri  methamine 
( m g )  
-7 0 5 10 15 20 
Days 
19 July 1973 1973 
Fig.1. Effect of Amodiaquine, Primaquine & Pyremethamine on a P. falciparum from 
Samarinda (Kalimantan, (formerly Borneo). 
2. Chloroquine. quine dose by the WHO malariologist. The 
After having received on September 1 and remaining asexual forms disappeared very 
3 respectively 450 mg amodiaquine base plus rapidly but on day 22 the patient was found 
50 mg pyrimethamine and 600 mg amodiaquine again with a moderate parasitaemia (1000 
base, the patient, with an already low asexual tr0phozoites Per mm3). Details are given 
parasitaemia, was given the standard chloro- in Table 3 and are illustrated in Fig 11- 
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Date Trophozo~tes Gametocytes Drug dose (mg base) R e m a r k s  
1 1  
Day 
Count * per rnm3 Count * per mrn3 
Sept. 1 - 4 450 31 50 0 0 arnodiaquine 450 Slck II 
pyrirnethamlne 51) 
,,. 2 - 3  - - - - 
I 
.. 3 - 2  50 350 0 0 arnodiaquine 600 
.. 4 - 1  15 105 0 0 
.. 5 0 3 21 1 only seen in chloroquine 600 chloroqyine given 
th~ck film by WHO 
malarlologist 1 
.. 6 1 0 0 1 only seen in chloroqulne 600 
thick film 
.. 7 2 0 0 2 only seen in chloroquine 300 
thick film 
.. 8 3 0 0 3 2 1 prirnaquine 15 
.. 9 4 0 0 2 14 prlmaquine 15 
.. 10 5 0 0 1 only seen in primaquine 15 
thick film 
.. 11 6 0 0 2 only seen in 
thlck film 
, 12 7 0 0 lon lyseen~n 
thick film 
.. 13 8 - - - - 
.. 14 9 - - - - 
,, 15 10 0 0 0 0 
,, 16 11 - - - - 
, 17 12 - - - - 
,, 18 13 0 0 0 0 
,, 19 14 - - - - 
,, 20 15 - - - - 
, 21 16 0 0 0 0 
,, 22 17 - - - - 
,, 23 18 - - - - 
, 24 19 0 0 0 0 
,, 25 20 - - - - 
,, 26 21 - - - - 
,, 27 22 110 770 0 0 asymptomatic 
,, 28 23 - - - - (except headache) 
, 29 24 45 31 5 0 0 arnodlaquine 450 
,, 30 25 15 105 0 0 
0ct. 1 26 5 35 0 0 
.. 2 27 8 56 0 0 Treatment 
.. 3 28 3 2 1 O I 0 delayed for 
,, 4 29 4 28 0 0 .  strain isolation 
.. 5 30 2 14 4 ' 28 
* : count per 1000 leucocytes Conclusion : R I  resistance, delayed recrudescence. 
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Parasi t es 
4 2 5 10 ,I5 
5+'\ Sept .I973 Days 
20 25 3 0 ~  
Gametocytes 
( per mm3 1 
A modiaquine 6 
( m g  b a s e )  3 
Pyrimet hamine 
( m g  1 
Chloroquine 
( mg ) 
' 4  0 . 5 10 15 20 25 30 
Primaquine 
( mg 1 
1 l 1 ~ ~ 1 ~ 1 1 1 1 1  J 1 1 1 1 1 1 1 1 1 ~  
Figlt. Effect of Arnodiaquine, Pyrimethamine, Chloroquine & frimaquiwgn a P. falciparum Strain 
drom Samarinda (Kelimantan, formerly Borneo). 
No urine test was carried out as there was no a g i n  of the  case 
Mayer-Tanret reagent available in the P z m h x ,  The #.bM frm Kampung Gedovgan (Yog- 
but there was neither vomiting nor diarrhea. yakarta Rwince,  Java), left his village for 
Kalimantan island i~ April 1972 and returned 
The parasite counts were carried out by the on 5 May 1973. The trip was ma@ by bus to  
LVHO laboratory specialist, Mr. R o o n e ~ .  Surabaya, then by boat to ~arnarinda (Fig. 111). 
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area in which infection occurred 
- ,,, - , itinerary followed by reported case from Szmarinda to 
3 Yogyakarta via Surabaya. 
Fig. I 11 .  Map of l ndonesia 
In Kalimantan the' patient worked for 2 from Samarinda and where he experienced at 
private Indonesian companies, Senlogaraya and least 3 severe attacks of fever which were 
Batutipang Co., building bridges and schools. treated by injections and tablets. Other symp. 
He stayed first on the outskirts of Samarinda toms were headache, rigor, sweating but no 
then in Lea Janan and Segiri Kecamatan. vomiting. 
In Lea Janan he worked in a forest area which There is no  malaria control in this are2 
can be reached by riverboat and foot in 2 hours control measures in Indonesia being mostly 
49 
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limted to the islands of Java and Bali. On the 
other hand Kampung Gedongan in Yogyakarta 
Province, is located in a special study area 
which is sprayed twice a year with DDT and 
where an effective surveillance system is main- 
tained, including active case detection, passive 
case detection and epidemiological investigati- 
ons. This mechanism, which also includes the 
systematic examination of persons returning 
from other Provinces, revealed, in addition to 
one imported P. vivax case from Gunung Kidul 
in August, 2 other cases in 1973. 
Two other cases found in the same Kampung. 
The ether two cases detected in Kampung 
Gedongan, Ponirnan andmArnad Jumeri are 2 
friends ofthe patient. They also went to  Kali- 
mantan and worked approximately in the same 
area but within a shorter period (five months). 
Both were detected on 10 May, five days 
after their return from Kalimantan, and both 
.were found positive for P. vivax. parasites. 
The interesting fact is that both had rec- 
rudescences of P. falciparum after receiving 
radical treatment for P. vivax. Further rec- 
rudescences occurred after repeated radical 
treatments and the infections had t o  be ter- 
minated with the association sulfadoxine and 
pyrimethamine. 
Both cases were obviously mixed infections 
with P. vivax predominating and resistant RI 
P. falciparum appearing only after the radical 
cure of P. vivax. In .one (Achmad Jumeri) 
P. falcipa&m rings started to  appear 2 days 
after the completion of the 14 days course bf 
primaquine. 
It is also significant to note that there has 
been no similar recrudescences detected amongst 
other imported or indigeneous cases followed 
up in the special study area of the Province of 
REFE 
Peters, W. (1970) chemotherapy and drug 
resistance .in malaria, Academic Prey. 
Clyde, D.F. (1973) characterisation of a drug 
Yogyakarta. On the other hand P. falciparum 
resistant strains have already been confirmed 
in Sabah, located north of East Kalimantan 
(see map). One imported resistant case from 
Tarakan has also been mentioned by Van Dijk 
(personal communication). 
Further studies will be carried out to deli- 
neate the infected area of Kalimantan, to 
identify the vector (which as in Sabah could be 
A. b. balabacensis) and to  take remedial mea- 
sures. 
SUMMARY AND CONCLUSION 
The first case of P. falciparum resistance 
to 4-aminoquinolines is reported from Indo- 
nesia. 
After a normal initial response the asexual 
parasites were found to.be resistant at the RI 
level to a standard regimen of 1500 mg 
amodiaquine base and to a standard regimen of 
1500 mg chloroquine base. 
The infection was contracted near Samarin- 
da, east of Kalimantan (formely Borneo). 
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